Journal: Brain stimulation
Article Title: Closed-loop deep brain stimulation effects on parkinsonian motor symptoms in a non-human primate -- is beta enough?
doi: 10.1016/j.brs.2016.06.051
Figure Lengend Snippet: Closed-loop DBS (CL-DBS) that delivers STN stimulation based on the level of beta activity in the STN has comparable therapeutic effect on rigidity compared to traditional DBS (tDBS) but does not improve performance on a cued reaching task. A) In the parkinsonian (MPTP) macaque used in this study, a peak (~14Hz) in the low beta range is present in the normalized power spectral density calculated from LFPs recorded from STN DBS electrode contacts 1–3. This plot was derived from LFPs recording during one of the 3 minute baseline recording sessions. B) Schematic of the system used to implement real-time CL-DBS, which incorporates Tucker Davis Technologies (TDT) hardware. LFPs were recorded from DBS contacts 1 and 3, subtracted to achieve a bipolar LFP signal and bandpass filtered (9–20Hz) to extract what we are defining as beta LFP (i). The beta amplitude envelope was calculated by rectifying and low-pass filtering by means of a 400ms moving average filter (ii). The threshold level for stimulation was fixed at the median of the beta amplitude envelope calculated from the baseline LFP recording acquired at the start of each experimental session. During CL-DBS, a trigger that was switched on/off whenever the beta amplitude was greater/less than the threshold (iii) controlled stimulation (Monopolar C2, 133Hz, 700μA, 80μs/phase, (iv)). An on/off ramp time (250ms) was employed to reduce potential paresthesias induced by switching on stimulation. C) Experiment design. Following the 3 min. baseline recording session, from which the CL-DBS trigger level was defined, an experiment block consisting of a control or stimulation (CL-DBS or tDBS) period, clinical rigidity assessment, behavior assessment, and washout; experiment blocks were repeated for each experimental condition: Off-DBS, tDBS, CL-DBS. The order of blocks was randomized each day. D) Schematic showing the cued reach behavior task. E) Rigidity scores for arm and leg joints based on blinded assessment during each condition (mean ± SE; P<0.05). F) Total movement time (left) and peak speeds during reach and return task epochs (middle,right) for each condition (mean and 95% C.I.; P<0.05). The “normal” condition reflects data collected when the animal was in the normal state before MPTP administration. G) Top: beta amplitude envelope averaged over all trials in each condition, aligned to reach onset (Time = 0 s). Bottom: DBS stimulus level (as a percentage of the maximum level) averaged over all trials in the CL-DBS condition, aligned to reach onset (Time = 0 s). a: mean reach duration, b: mean return duration
Article Snippet: Data were collected from one female rhesus macaque (25 yr.) rendered parkinsonian by two intra-carotid and two systemic injections of the neurotoxin 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and implanted in the STN with a 4-contact scaled version of a human DBS lead (NuMed) using standard approaches described elsewhere [ 19 ].
Techniques: Activity Assay, Derivative Assay, Blocking Assay, Control